Quantcast

Latest Bisphosphonates Stories

2012-05-23 23:03:12

Bernstein Liebhard LLP reports on a new study that found an increased risk of atypical femur fractures in people who take Fosamax. New York, New York (PRWEB) May 22, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who experienced Fosamax thigh fractures and other side effects, reports on a May 21, 2012 study by the Archives of Internal Medicine, which found that taking Fosamax increases the risk of an atypical femur fracture.* The study was conducted by doctors from...

2012-05-21 23:02:11

Bernstein Liebhard LLP reports on a study, which found that the FDA approved more new drugs quicker than health regulatory agencies in Europe and Canada. New York, New York (PRWEB) May 21, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who experienced complications from dangerous drugs such as Fosamax, reports on a May 16, 2012 study published in The New England Journal of Medicine (“NEJM”) that found that the U.S. Food and Drug Administration...

2012-05-17 05:15:41

(Ivanhoe Newswire) -- New research shows when it comes to bone-cancer-related fractures, pain can be reduced by drug treatment, but no one drug is superior. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma. Severe back pain is a common symptom of multiple myeloma–a type of cancer that can cause fractures in long bones and the spine. Bisphosphonate drugs may help to reduce the...

2012-05-16 11:07:11

Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior, according to a review published in The Cochrane Library. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma. Multiple myeloma is a type of cancer that grows in and on bones, and can cause fractures in long bones and the spine. Severe back pain is a common symptom. Bisphosphonate drugs may help...

2012-05-12 23:00:26

Ennis & Ennis P.A. Announces Free Nationwide Consultations to Patients Who Have Suffered Fosamax Femur Fractures or Osteonecrosis of the Jaw as FDA Confirms Long-Term Use of Fosamax Weakens Bones (PRWEB) May 12, 2012 According to an FDA review of biphosphonates published on May 9, 2012 in the New England Journal of Medicine, long term use of these drugs, commonly known as Boniva or Fosamax, could lead to weakened bones. In these cases, women suffered Fosamax side effects including...

FDA Report Suggests Women Reassess Bone Drug Use Due To Serious Adverse Events
2012-05-11 12:45:33

A new analysis of popular bone-building drugs by the US Food and Drug Administration (FDA) could prompt millions of women to rethink their use of such drugs, even though the agency fell short of issuing specific recommendations. The FDA said doctors need to reassess which women are likely to benefit from bisphosphonates such as Fosamax, Actonel and Reclast, given the lack of concrete evidence that taking them over long periods really helps them and the possibility that they can put some...

2012-05-10 09:50:59

ASBMR calls for more research to refine recommendations further The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called bisphosphonates after three to five years of therapy to determine whether they should continue treatment. Bisphosphonates are a widely prescribed class of drugs that are proven to be effective in reducing common bone fractures in people with osteoporosis and at...

2012-05-10 09:47:22

Previous UCSF Research Found Overall Reduction in Spine Fractures, But Not for Other Types of Fractures Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate — a class of drugs that prevent...

2012-04-05 23:00:46

On March 19th, 2012 the US FDA announced the approval of the first Boniva generics to treat or prevent osteoporosis. Boniva and Fosamax belong to the class of drugs known as bisphosphonates. Fosamax, manufactured by Merck, is a drug approved by the FDA in 1995 to treat osteoporosis and other bone-related diseases. On February 27th, 2012, a jury trial began in the Superior Court for Atlantic County, New Jersey in In re: Fosamax Litigation (No. 282). Plaintiffs allege that using Fosamax caused...

2012-04-02 23:00:59

The US Drug Watchdog is saying, "We want to make certain every woman in the United States who used the osteoporosis drug called Fosamax and then suffered an out of the blue femur break gets identified, and we want to make certain they get to the best possible personal injury attorneys, so they get the maximum possible compensation for what they have been through. Most women victims we have spoken with describe the experience as the post painful of their lives." These type of leg breaks are...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related